$VIVK
Vivakor, Inc. Stock $vivk

$vivk Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000182912624007695 Filed on November 19, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$15.92M	$16.31M
YoY Change		-2.43%	38.65%
Cost Of Revenue		$14.19M	$14.77M
YoY Change		-3.9%	39.92%
Gross Profit		$1.726M	$1.547M
YoY Change		11.6%	27.57%
Gross Profit Margin		10.85%	9.48%
Selling, General & Admin		$2.620M	$1.475M
YoY Change		77.63%	-39.15%
% of Gross Profit		151.77%	95.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$1.065M	$819.5K
YoY Change		29.96%	-26.82%
% of Gross Profit		61.69%	52.97%
Operating Expenses		$3.685M	$2.292M
YoY Change		60.77%	-35.32%
Operating Profit		-$1.958M	-$745.1K
YoY Change		162.83%	-68.03%
Interest Expense		$641.2K	$516.4K
YoY Change		24.19%	-9.07%
% of Operating Profit
Other Income/Expense, Net		$218.4K	-$1.907M
YoY Change		-111.46%	-435.76%
Pretax Income		-$1.740M	-$2.652M
YoY Change		-34.38%	50.42%
Income Tax
% Of Pretax Income
Net Earnings		-$1.688M	-$2.517M
YoY Change		-32.94%	42.79%
Net Earnings / Revenue		-10.61%	-15.43%
Basic Earnings Per Share		-$0.06	-$0.14
Diluted Earnings Per Share		-$0.06	-$0.14
COMMON SHARES
Basic Shares Outstanding	33.64M shares	29.28M shares	18.06M shares
Diluted Shares Outstanding		30.63M shares	18.12M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.927M	$1.860M
YoY Change	3.58%	-74.4%
Cash & Equivalents	$687.2K	$1.018M
Short-Term Investments	$1.240M	$661.1K
Other Short-Term Assets	$1.639M	$1.049M
YoY Change	56.22%	33.66%
Inventory	$184.9K	$63.68K
Prepaid Expenses	$81.48K	$67.35K
Receivables	$691.9K	$3.832M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.661M	$7.046M
YoY Change	-33.85%	-53.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$28.35M	$26.69M
YoY Change	6.21%	-15.39%
Goodwill	$14.98M	$14.98M
YoY Change	0.0%	128.36%
Intangibles
YoY Change
Long-Term Investments	$4.000K	$4.000K
YoY Change	0.0%	0.0%
Other Assets
YoY Change
Total Long-Term Assets	$67.88M	$69.07M
YoY Change	-1.72%	-13.22%
TOTAL ASSETS
Total Short-Term Assets	$4.661M	$7.046M
Total Long-Term Assets	$67.88M	$69.07M
Total Assets	$72.54M	$76.12M
YoY Change	-4.69%	-19.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.071M	$3.750M
YoY Change	115.23%	-42.53%
Accrued Expenses	$3.721M	$4.418M
YoY Change	-15.77%	35.08%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$25.49M	$14.36M
YoY Change	77.58%	239.29%
Total Short-Term Liabilities	$47.13M	$26.03M
YoY Change	81.06%	85.03%
LONG-TERM LIABILITIES
Long-Term Debt	$7.355M	$25.00M
YoY Change	-70.58%	-33.45%
Other Long-Term Liabilities	$1.199M	$1.181M
YoY Change	1.5%	248.98%
Total Long-Term Liabilities	$8.554M	$26.18M
YoY Change	-67.33%	-30.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$47.13M	$26.03M
Total Long-Term Liabilities	$8.554M	$26.18M
Total Liabilities	$55.80M	$52.21M
YoY Change	6.88%	-8.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$72.79M	-$62.07M
YoY Change	17.28%	44.96%
Common Stock	$5.000M	$18.22K
YoY Change	27342.37%	0.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.80M	$13.91M
YoY Change
Total Liabilities & Shareholders Equity	$72.54M	$76.12M
YoY Change	-4.69%	-19.71%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$1.688M	-$2.517M
YoY Change	-32.94%	42.79%
Depreciation, Depletion And Amortization	$1.065M	$819.5K
YoY Change	29.96%	-26.82%
Cash From Operating Activities	$990.7K	$461.3K
YoY Change	114.75%	-171.61%
INVESTING ACTIVITIES
Capital Expenditures	$186.1K	$1.812M
YoY Change	-89.73%	-367.35%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$186.1K	-$1.812M
YoY Change	-89.73%	211.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-212.4K	-83.41K
YoY Change	154.62%	-115.37%
NET CHANGE
Cash From Operating Activities	990.7K	461.3K
Cash From Investing Activities	-186.1K	-1.812M
Cash From Financing Activities	-212.4K	-83.41K
Net Change In Cash	592.2K	-1.434M
YoY Change	-141.31%	109.97%
FREE CASH FLOW
Cash From Operating Activities	$990.7K	$461.3K
Capital Expenditures	$186.1K	$1.812M
Free Cash Flow	$804.6K	-$1.350M
YoY Change	-159.59%	-4139.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1473728	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7252540	usd
	us-gaap	Operating Expenses OperatingExpenses	6982754	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-745114	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6427973	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Central Index Key EntityCentralIndexKey	0001450704
	dei	Document Type DocumentType	10-Q
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-2178141
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5220 Spring Valley Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75242
	dei	City Area Code CityAreaCode	949
	dei	Local Phone Number LocalPhoneNumber	281-2606
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	VIVK
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	744307	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2458730	usd
CY2023Q4	vivk	Accounts Receivable Related Party AccountsReceivableRelatedParty	174083	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	74876	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Marketable Securities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities	495826	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	44632	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1118188	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5110642	usd
CY2023Q4	us-gaap	Other Investments OtherInvestments	4000	usd
CY2023Q4	vivk	Notes Receivable NotesReceivable	213168	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24299317	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1534870	usd
CY2023Q4	vivk	License Agreement Net LicenseAgreementNet	1651324	usd
CY2023Q4	vivk	Intellectual Property Net IntellectualPropertyNet	23437654	usd
CY2023Q4	vivk	Accrued Compensation AccruedCompensation	1968063	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	435906	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	963900	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	2477970	usd
CY2023Q4	vivk	Loans And Notes Payable Related Partiescurrent LoansAndNotesPayableRelatedPartiescurrent	15626168	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	39984466	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1193915	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1852178	usd
CY2023Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	856034	usd
CY2023Q4	vivk	Loans And Notes Payable Long Term Related Party LoansAndNotesPayableLongTermRelatedParty	5590008	usd
CY2023Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	4433630	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	88323	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	26221	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65908406	usd
CY2023Q3	us-gaap	Revenues Revenues	16313406	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	14766494	usd
	us-gaap	Cost Of Revenue CostOfRevenue	44213635	usd
	us-gaap	Cost Of Revenue CostOfRevenue	41174082	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1546912	usd
	us-gaap	Gross Profit GrossProfit	3905301	usd
	us-gaap	Gross Profit GrossProfit	4274834	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1240	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	18318	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4710852	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	817058	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3062416	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2269445	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2292026	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2707920	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	743739	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-991652	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	516357	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-522022	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4682369	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2651891	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6949995	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7390289	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-2651891	usd
	us-gaap	Profit Loss ProfitLoss	-6983978	usd
	us-gaap	Profit Loss ProfitLoss	-7391089	usd
CY2023Q3	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-134517	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-100593	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-494450	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2517374	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6883385	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6896639	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2024Q3	vivk	Loans And Notes Payable Long Term Related Party LoansAndNotesPayableLongTermRelatedParty		usd
CY2024Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2023Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
CY2024Q3	vivk	Interest Expense Related Parties InterestExpenseRelatedParties		usd
	vivk	Interest Expense Related Parties InterestExpenseRelatedParties		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	vivk	Gain On Deconsolidation Of Variable Interest Entity GainOnDeconsolidationOfVariableInterestEntity		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet		usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	vivk	Noncontrolling Interest Issued For Reduction In Liabilities NoncontrollingInterestIssuedForReductionInLiabilities		usd
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1		usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1		usd
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1		usd
	us-gaap	Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1 NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1		usd
CY2024Q3	vivk	Office Access Deposits OfficeAccessDeposits		usd
CY2023Q4	vivk	Office Access Deposits OfficeAccessDeposits		usd
CY2024Q3	vivk	Loans And Notes Payable Long Term Related Parties LoansAndNotesPayableLongTermRelatedParties		usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-41286
	dei	Entity Registrant Name EntityRegistrantName	VIVAKOR, INC.
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33638273	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	687172	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	691895	usd
CY2024Q3	vivk	Accounts Receivable Related Party AccountsReceivableRelatedParty	137000	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	81484	usd
CY2024Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Marketable Securities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities	1239565	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	184882	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1639084	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	4661082	usd
CY2024Q3	us-gaap	Other Investments OtherInvestments	4000	usd
CY2024Q3	vivk	Notes Receivable NotesReceivable	220088	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28348642	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1283378	usd
CY2024Q3	vivk	License Agreement Net LicenseAgreementNet	1560703	usd
CY2024Q3	vivk	Intellectual Property Net IntellectualPropertyNet	21481049	usd
CY2024Q3	us-gaap	Goodwill Goodwill	14984768	usd
CY2023Q4	us-gaap	Goodwill Goodwill	14984768	usd
CY2024Q3	us-gaap	Assets Assets	72543710	usd
CY2023Q4	us-gaap	Assets Assets	71235743	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	19635178	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	16578642	usd
CY2024Q3	vivk	Accounts Payable And Accrued Expenses Related Parties AccountsPayableAndAccruedExpensesRelatedParties	778559	usd
CY2023Q4	vivk	Accounts Payable And Accrued Expenses Related Parties AccountsPayableAndAccruedExpensesRelatedParties	1933817	usd
CY2024Q3	vivk	Accrued Compensation AccruedCompensation	1046481	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	177249	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	717828	usd
CY2024Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	3236529	usd
CY2024Q3	vivk	Loans And Notes Payable Related Partiescurrent LoansAndNotesPayableRelatedPartiescurrent	21538331	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	47130154	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1199082	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1734193	usd
CY2024Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	355812	usd
CY2024Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	5264818	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	120076	usd
CY2024Q3	us-gaap	Liabilities Liabilities	55804135	usd
CY2023Q4	us-gaap	Liabilities Liabilities	53998554	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33638273	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33638273	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26220508	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26220508	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	33638	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	89576500	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83097553	usd
CY2024Q3	us-gaap	Treasury Stock Carrying Basis TreasuryStockCarryingBasis	20000	usd
CY2023Q4	us-gaap	Treasury Stock Carrying Basis TreasuryStockCarryingBasis	20000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72791791	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	16798347	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	17195368	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	-58772	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	41821	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16739575	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17237189	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	72543710	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71235743	usd
CY2024Q3	us-gaap	Revenues Revenues	15916423	usd
	us-gaap	Revenues Revenues	48118936	usd
	us-gaap	Revenues Revenues	45448916	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	14190073	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1726350	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6650	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2457	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2613394	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1064943	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	3684987	usd
	us-gaap	Operating Expenses OperatingExpenses	10333274	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1958367	usd
CY2024Q3	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	826377	usd
CY2023Q3	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-661101	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	177550	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	2307	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	6920	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	641244	usd
	us-gaap	Interest Expense InterestExpense	1565231	usd
	us-gaap	Interest Expense InterestExpense	1426730	usd
CY2023Q3	vivk	Interest Expense Related Parties InterestExpenseRelatedParties	828739	usd
	vivk	Interest Expense Related Parties InterestExpenseRelatedParties	2387523	usd
CY2024Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	31000	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	99420	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	115000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	123536	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	218440	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1906777	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1740197	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33983	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-1740197	usd
CY2024Q3	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-52045	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1688152	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30625756	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30625756	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18120344	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18120344	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28282472	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28282472	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18083543	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18083543	shares
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15033565	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	353850	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1425000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1179000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	488357	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-1740197	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16739575	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17237189	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	735650	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1425000	usd
	vivk	Issuance Of Common Stock Issued For Reduction Of Liabilities IssuanceOfCommonStockIssuedForReductionOfLiabilities	379290	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2227493	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	92522	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1626409	usd
	us-gaap	Profit Loss ProfitLoss	-6983978	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16739575	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23518136	usd
CY2023Q3	vivk	Issuance Of Common Stock Issued For Reduction Of Liabilities IssuanceOfCommonStockIssuedForReductionOfLiabilities	220000	usd
CY2023Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	414328	usd
CY2023Q3	vivk	Issuance Of Noncontrolling Interest For Reduction Of Debt IssuanceOfNoncontrollingInterestForReductionOfDebt	1970000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1260476	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-2651891	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23902393	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27061061	usd
	vivk	Issuance Of Common Stock Issued For Reduction Of Liabilities IssuanceOfCommonStockIssuedForReductionOfLiabilities	220000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1020564	usd
	vivk	Issuance Of Noncontrolling Interest For Reduction Of Debt IssuanceOfNoncontrollingInterestForReductionOfDebt	3305000	usd
	vivk	Nonqualified Stock Options Issued To Third Party NonqualifiedStockOptionsIssuedToThirdParty	467509	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1260476	usd
	us-gaap	Profit Loss ProfitLoss	-7391089	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23902393	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6983978	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7391089	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3062416	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2269445	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	40584	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1626409	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1260476	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	743739	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-991652	usd
	vivk	Gain On Deconsolidation Of Variable Interest Entity GainOnDeconsolidationOfVariableInterestEntity	177550	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	31753	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1753918	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	442307	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	6608	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	35822	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	140250	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16500	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	520896	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	348943	usd
	vivk	Right Of Use Assets Finance Leases RightOfUseAssetsFinanceLeases	-26648	usd
	vivk	Right Of Use Assets Finance Leases RightOfUseAssetsFinanceLeases	785817	usd
	vivk	Right Of Use Assets Operating Leases RightOfUseAssetsOperatingLeases	251492	usd
	vivk	Right Of Use Assets Operating Leases RightOfUseAssetsOperatingLeases	257286	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-253490	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-257286	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1184103	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-929360	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	6920	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1115347	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	3058522	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	165359	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-838693	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2362898	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3841589	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2362898	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3841589	usd
	vivk	Payment On Financing Lease Liabilities PaymentOnFinancingLeaseLiabilities	364057	usd
	vivk	Payment On Financing Lease Liabilities PaymentOnFinancingLeaseLiabilities	299993	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3365309	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3723458	usd
	vivk	Proceeds From Loans And Notes Payable Related Party ProceedsFromLoansAndNotesPayableRelatedParty	1304150	usd
	vivk	Proceeds From Loans And Notes Payable Related Party ProceedsFromLoansAndNotesPayableRelatedParty	776500	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1425000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1439461	usd
	vivk	Payment Of Notes Payable Related Party PaymentOfNotesPayableRelatedParty	2150537	usd
	vivk	Payment Of Notes Payable Related Party PaymentOfNotesPayableRelatedParty	482815	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1020564	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2140404	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2696586	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-57135	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1983696	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	744307	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3182793	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	687172	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	1199097	usd
	us-gaap	Interest Paid Net InterestPaidNet	460343	usd
	us-gaap	Interest Paid Net InterestPaidNet	2485211	usd
	vivk	Accounts Payable On Purchase Of Equipment AccountsPayableOnPurchaseOfEquipment	1571608	usd
	vivk	Accounts Payable On Purchase Of Equipment AccountsPayableOnPurchaseOfEquipment	432857	usd
	vivk	Noncontrolling Interest Issued For Reduction In Liabilities NoncontrollingInterestIssuedForReductionInLiabilities	3305000	usd
	vivk	Capitalized Interest On Construction In Process CapitalizedInterestOnConstructionInProcess	1015402	usd
	vivk	Capitalized Interest On Construction In Process CapitalizedInterestOnConstructionInProcess	735919	usd
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	464290	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	467509	usd
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	735650	usd
	us-gaap	Noncash Or Part Noncash Acquisition Employee Benefit Liabilities Assumed1 NoncashOrPartNoncashAcquisitionEmployeeBenefitLiabilitiesAssumed1	2227493	usd
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	379290	usd
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	220000	usd
	vivk	Revenue From Related Party RevenueFromRelatedParty	17119485	usd
	vivk	Revenue From Related Party RevenueFromRelatedParty	9834095	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_ztMD984y2ixi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zDj97gNlgcij">Major Customers and Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has two major customers, which account for approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_pdd" title="Concentration risk, percentage"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_pdd" title="Concentration risk, percentage">99%</span></span> of the balance of accounts receivable as of September 30, 2024 and 2023. Our two major customers (one of which is a related party) accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_pdd" title="Concentration risk, percentage"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_pdd" title="Concentration risk, percentage">99%</span></span> of the Company’s revenues for the nine months ended September 30, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Advertising Expense AdvertisingExpense	0	usd
	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	399040	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	399040	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zW4pEF9xYBxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zWaa5QQWjhEh">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates, judgments, and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We believe our critical accounting estimates relate to the following: Recoverability of current and noncurrent assets, stock-based compensation, income taxes, effective interest rates related to long-term debt, lease assets and liabilities, valuation of stock used to acquire assets, derivatives, and fair values of the intangible assets and goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While our estimates and assumptions are based on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72791791	usd
CY2024Q3	vivk	Working Capital Deficit WorkingCapitalDeficit	42500000	usd
CY2023Q3	vivk	Working Capital Deficit WorkingCapitalDeficit	19000000	usd
CY2024Q3	us-gaap	Cash Cash	687000	usd
	vivk	Obligations Pay Description ObligationsPayDescription	we have current obligations to pay approximately $24.8 million of debt. Of the $24.8 million, $13.8 million can be satisfied through the issuance of registered common stock under the terms of the debt. Approximately $13 million ($9.1 million of unearned revenue $3.9 million in accounts payable (Note 5)) is related to the sale leaseback of our Remediation Processing Unit A & B, wash plant facilities, and our White Claw Colorado City site pipeline extension. Once construction is completed of these sites, of the $13 million, approximately $7.1 million will be financed over eight years and $3.9 million (Note 7) will be financed over four years. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.
	vivk	Description Of Subject To Available Cashflow DescriptionOfSubjectToAvailableCashflow	the Company continued to develop its technologies, its strategy to monetize its intellectual properties and execute its business plan. To date we have financed our operations primarily through debt financing, private and public equity offerings and our working interest agreements. For the fiscal year 2023 we raised approximately $3 million through debt financings with individual investors, $2.2 million through a sale lease back agreement. During the nine months ended September 30, 2024, we raised an additional $4.7 million through debt financings and $1.4 million through the sale of common stock.
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	31210028	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2861386	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28348642	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	26260120	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1960803	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24299317	usd
	us-gaap	Depreciation Depreciation	114765	usd
	us-gaap	Depreciation Depreciation	111452	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	33287347	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11806298	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21481049	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	33287347	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9849693	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23437654	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	12678108	usd
CY2023	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	2306660	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	14984768	usd
CY2024Q3	us-gaap	Goodwill Gross GoodwillGross	14984768	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	8070842	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5226071	usd
CY2024Q3	us-gaap	Unearned Premiums UnearnedPremiums	9107297	usd
CY2023Q4	us-gaap	Unearned Premiums UnearnedPremiums	9107297	usd
CY2024Q3	vivk	Accrued Interest Various Notes And Loans Payable AccruedInterestVariousNotesAndLoansPayable	122331	usd
CY2023Q4	vivk	Accrued Interest Various Notes And Loans Payable AccruedInterestVariousNotesAndLoansPayable	178999	usd
CY2024Q3	vivk	Accrued Interest Working Interest Royalty Programs AccruedInterestWorkingInterestRoyaltyPrograms	1591907	usd
CY2023Q4	vivk	Accrued Interest Working Interest Royalty Programs AccruedInterestWorkingInterestRoyaltyPrograms	1396528	usd
CY2024Q3	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	742801	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	669747	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	19635178	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	16578642	usd
CY2024Q3	vivk	Accounts Payable Related Parties AccountsPayableRelatedParties	738633	usd
CY2023Q4	vivk	Accounts Payable Related Parties AccountsPayableRelatedParties	1933817	usd
CY2024Q3	vivk	Accrued Interest Notes Payable Related Parties AccruedInterestNotesPayableRelatedParties	39926	usd
CY2023Q4	vivk	Accrued Interest Notes Payable Related Parties AccruedInterestNotesPayableRelatedParties	0	usd
CY2024Q3	vivk	Accounts Payable And Accrued Expenses Related Parties AccountsPayableAndAccruedExpensesRelatedParties	778559	usd
CY2023Q4	vivk	Accounts Payable And Accrued Expenses Related Parties AccountsPayableAndAccruedExpensesRelatedParties	1933817	usd
CY2024Q3	vivk	Accrued Compensation AccruedCompensation	1046481	usd
CY2023Q4	vivk	Accrued Compensation AccruedCompensation	1968063	usd
CY2024Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	371075	usd
CY2024Q3	vivk	Accounts Payable Related To Services Rendered AccountsPayableRelatedToServicesRendered	596341	usd
CY2023Q4	vivk	Accounts Payable Related To Services Rendered AccountsPayableRelatedToServicesRendered	178325	usd
	vivk	New Executive Employment Agreement Description NewExecutiveEmploymentAgreementDescription	we entered into a new executive employment agreement with our Vice President, Marketing. Pursuant to the new employment agreement, our Vice President, Marketing will receive $200,000 annually (the “Base Salary”), which after the first annual anniversary the Base Salary may increase to $350,000 contingent upon the Company achieving net profitability of $500,000 of all commodity trades by the Vice President, Marketing. In addition, the employment agreement provides for annual incentive cash and equity compensation of up to $440,000 based on certain performance goals as further set forth therein. As an inducement to enter into the executive employment agreement, the Vice President, Marketing is entitled to receive a one-time signing grant of Company common stock equivalent in value to $150,000, which is priced per share based on the closing price on the day of such grant (calculated to be 71,090 shares based on the effective date of the executive employment agreement). The signing bonus has not been issued and is due not later than thirty (30) calendar days after we file an amended Registration Statement on Form S-8 with the Securities and Exchange Commission registering shares under a Long-Term Incentive Plan (“LTIP”), and the shares will only vest as set forth in the LTIP.
CY2024Q3	us-gaap	Notes Payable NotesPayable	3592341	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	3334004	usd
CY2024Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	3236529	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	2477970	usd
CY2024Q3	vivk	Notes And Loans Payable Non Current NotesAndLoansPayableNonCurrent	355812	usd
CY2023Q4	vivk	Notes And Loans Payable Non Current NotesAndLoansPayableNonCurrent	856034	usd
CY2024Q3	us-gaap	Other Notes Payable OtherNotesPayable	21538331	usd
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	21216176	usd
CY2024Q3	vivk	Loans And Notes Payable Current Related Parties LoansAndNotesPayableCurrentRelatedParties	21538331	usd
CY2023Q4	vivk	Loans And Notes Payable Current Related Parties LoansAndNotesPayableCurrentRelatedParties	15626168	usd
CY2023Q4	vivk	Loans And Notes Payable Long Term Related Parties LoansAndNotesPayableLongTermRelatedParties	5590008	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	17313784	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	7519146	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	35552	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	17232	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	17232	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	227726	usd
CY2024Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	25130672	usd
CY2024Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	32161	usd
CY2024Q3	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	374702	usd
CY2024Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	58595	usd
CY2024Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	683000	usd
CY2024Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	57962	usd
CY2024Q2	vivk	Fair Market Value FairMarketValue	685000	usd
CY2024Q3	vivk	New Executive Employment Agreement Description NewExecutiveEmploymentAgreementDescription	we entered into a new executive employment agreement with our Vice President, Marketing. Pursuant to the new employment agreement, our Vice President, Marketing will receive $200,000 annually (the “Base Salary”), which after the first annual anniversary the Base Salary may increase to $350,000 contingent upon the Company achieving net profitability of $500,000 of all commodity trades by the Vice President, Marketing. In addition, the employment agreement provides for annual incentive cash and equity compensation of up to $440,000 based on certain performance goals as further set forth therein. As an inducement to enter into the executive employment agreement, the Vice President, Marketing is entitled to receive a one-time signing grant of Company common stock equivalent in value to $150,000, which are priced per share based on the closing price on the day of such grant (calculated to be 71,090 shares based on the effective date of the executive employment agreement). The signing bonus has not been issued and is due not later than thirty (30) calendar days after we file an amended Registration Statement on Form S-8 with the Securities and Exchange Commission registering shares under a Long-Term Incentive Plan (“LTIP”), and the shares will only vest as set forth in the LTIP.
	vivk	Additional Shares Issued AdditionalSharesIssued	450244	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1657016	shares
	vivk	Share Purchased SharePurchased	245536	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	1626409	usd
	vivk	Nonstatutory Stockbased Compensation NonstatutoryStockbasedCompensation	92522	usd
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33983	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0073	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0087	pure
CY2024Q4	vivk	Purchase Price PurchasePrice	120000000	usd
CY2024Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q4	vivk	Executive Employment Agreements Description ExecutiveEmploymentAgreementsDescription	Company entered into an executive employment agreement with Russ Shelton (the “Shelton Agreement”) with respect to the Company’s appointment of Mr. Shelton as Executive Vice President and Chief Operating Officer of the Company. Pursuant to the Shelton Agreement, Mr. Shelton will receive (i) base salary compensation of $337,000 USD annually (the “Base Compensation”); (ii) an annual cash and equity incentive compensation of up to $808,000 based upon certain performance criteria as more particularly described therein. As an inducement to enter into the Shelton Agreement, Mr. Shelton shall receive a one-time signing grant of Company common stock equivalent in value to $150,000, which are priced per share based on the volume-weighted average price for the preceding five (5) trading days prior to the day of such grant, subject to an eighteen (18)-month lockup period, which shall be granted promptly after the Effective Date, as defined therein. Pursuant to the Shelton Agreement, Mr. Shelton’s employment is at-will under Texas law, except as modified therein.
CY2024Q4	vivk	Annual Base Salary AnnualBaseSalary	325000	usd
CY2024Q4	vivk	Original Principal Amount OriginalPrincipalAmount	12500000	usd
CY2024Q4	vivk	Proceeds From Promissory Note ProceedsFromPromissoryNote	530000	usd
CY2024Q4	vivk	Repayment Of Promissory Note RepaymentOfPromissoryNote	530000	usd
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001829126-24-007695-index-headers.html	Edgar Link	pending
0001829126-24-007695-index.html	Edgar Link	pending
0001829126-24-007695.txt	Edgar Link	pending
0001829126-24-007695-xbrl.zip	Edgar Link	pending
ex10-39_001.jpg	Edgar Link	pending
ex10-39_002.jpg	Edgar Link	pending
ex10-42_001.jpg	Edgar Link	pending
ex10-43_001.jpg	Edgar Link	pending
ex10-43_002.jpg	Edgar Link	pending
ex10-50_001.jpg	Edgar Link	pending
ex10-52_001.jpg	Edgar Link	pending
ex10-54_001.jpg	Edgar Link	pending
ex10-54_002.jpg	Edgar Link	pending
ex10-56_001.jpg	Edgar Link	pending
ex10-57_001.jpg	Edgar Link	pending
ex10-59_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vivakor_10q.htm	Edgar Link	pending
vivakor_ex10-35.htm	Edgar Link	pending
vivakor_ex10-36.htm	Edgar Link	pending
vivakor_ex10-37.htm	Edgar Link	pending
vivakor_10q_htm.xml	Edgar Link	completed
vivakor_ex10-38.htm	Edgar Link	pending
vivakor_ex10-39.htm	Edgar Link	pending
vivakor_ex10-40.htm	Edgar Link	pending
vivakor_ex10-41.htm	Edgar Link	pending
vivakor_ex10-42.htm	Edgar Link	pending
vivakor_ex10-43.htm	Edgar Link	pending
vivakor_ex10-44.htm	Edgar Link	pending
vivakor_ex10-45.htm	Edgar Link	pending
vivakor_ex10-46.htm	Edgar Link	pending
vivakor_ex10-47.htm	Edgar Link	pending
vivakor_ex10-48.htm	Edgar Link	pending
vivakor_ex10-49.htm	Edgar Link	pending
vivakor_ex10-50.htm	Edgar Link	pending
vivakor_ex10-51.htm	Edgar Link	pending
vivakor_ex10-52.htm	Edgar Link	pending
vivakor_ex10-53.htm	Edgar Link	pending
vivakor_ex10-54.htm	Edgar Link	pending
vivakor_ex10-55.htm	Edgar Link	pending
vivakor_ex10-56.htm	Edgar Link	pending
vivakor_ex10-57.htm	Edgar Link	pending
vivakor_ex10-58.htm	Edgar Link	pending
vivakor_ex10-59.htm	Edgar Link	pending
vivakor_ex31-1.htm	Edgar Link	pending
vivakor_ex31-2.htm	Edgar Link	pending
vivakor_ex32-1.htm	Edgar Link	pending
vivakor_ex32-2.htm	Edgar Link	pending
vivakor_ex4-4.htm	Edgar Link	pending
vivk-20240930.xsd	Edgar Link	pending
vivk-20240930_cal.xml	Edgar Link	unprocessable
vivk-20240930_def.xml	Edgar Link	unprocessable
vivk-20240930_lab.xml	Edgar Link	unprocessable
vivk-20240930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VIVK
Vivakor, Inc. Stock $vivk

2024 Q4 Form 10-Q Financial Statement

#000182912624007695 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VIVK Vivakor, Inc. Stock $vivk

2024 Q4 Form 10-Q Financial Statement

#000182912624007695 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VIVK
Vivakor, Inc. Stock $vivk